Clínic-IDIBAPS, a key role in developing the Hipra vaccine
The HIPRA vaccine against COVID-19 is the first vaccine authorised for human health that has been designed and developed in Spain, and various serv...
The HIPRA vaccine against COVID-19 is the first vaccine authorised for human health that has been designed and developed in Spain, and various serv...
A study in which IDIBAPS researchers took part has found new alterations that cause loss of function in the BMPR2 gene, leading to uncontrolled pro...
It currently contains a conservation fund of more than 250,000 nervous tissue samples that allows researchers to study a wide range of neurodegener...
The new protocol, published in Nature Neuroscience, defines the parameters for optimum identification of functional networks through resting-state...
One in three patients in the study had a “viral storm”, showing signs of an increased inflammatory response.
Campus Clínic has celebrated today St George’s Day (Sant Jordi). During the celebrations, the Sixth IDIBAPS Scientific Photography Competition winn...
Hospital Clínic Barcelona will participate in the second edition of Endofest, a charity music festival that seeks to raise awareness about endome...
Over the next three years, the Xartec, Tecsam and i4kids networks will promote innovation in the fields of health technologies, mental health and p...
The study, published by the Journal of Cachexia, Sarcopenia and Muscle, concludes that skin fibroblast cultures derived from patients reproduce the...
Researchers from the Hospital Clínic-IDIBAPS have co-led a document on the management of severe community-acquired pneumonia, published simultaneou...